Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Heart Failure With Preserved Ejection Fraction (D-HART2)
NCT02173548Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Sep 2014
- Primary completion
- Apr 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in heart failure with preserved ejection fraction (HFpEF), sponsored by Virginia Commonwealth University. Started Sep 2014; status: completed.
02
Drugs
anakinra
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT02173548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02173548.